Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | 139,000 | 348,000 | 805,000 | 316,000 | -92,000 |
| Other Working Capital | -600,000 | -523,000 | 3,242,000 | -577,000 | -372,000 |
| Other Operating Activity | 1,823,000 | 1,038,000 | -1,178,000 | 2,158,000 | 1,472,000 |
| Operating Cash Flow | $1,362,000 | $863,000 | $2,869,000 | $1,897,000 | $1,008,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -270,000 | -249,000 | -395,000 | -355,000 | -267,000 |
| Net Acquisitions | 54,000 | -85,000 | 161,000 | -7,000 | 22,000 |
| Purchase Sale Intangibles | -74,000 | -92,000 | -120,000 | -118,000 | -215,000 |
| Other Investing Activity | 46,000 | 60,000 | 43,000 | 24,000 | 31,000 |
| Investing Cash Flow | $-262,000 | $-371,000 | $-335,000 | $-462,000 | $-447,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -253,000 | 701,000 | -1,756,000 | -1,830,000 | 914,000 |
| Common Stock Issued | 12,000 | 11,000 | 8,000 | 3,000 | 13,000 |
| Common Stock Repurchased | 0 | 0 | -5,000 | 1,000 | 0 |
| Dividend Paid | -1,130,000 | -929,000 | -929,000 | -928,000 | -1,124,000 |
| Other Financing Activity | 181,000 | -66,000 | -575,000 | 2,105,000 | -768,000 |
| Financing Cash Flow | $-1,190,000 | $-283,000 | $-3,257,000 | $-649,000 | $-965,000 |
| Exchange Rate Effect | 18,000 | -52,000 | -23,000 | -31,000 | -57,000 |
| Beginning Cash Position | 3,757,000 | 3,600,000 | 4,346,000 | 3,591,000 | 4,052,000 |
| End Cash Position | 3,685,000 | 3,757,000 | 3,600,000 | 4,346,000 | 3,591,000 |
| Net Cash Flow | $-90,000 | $209,000 | $-723,000 | $786,000 | $-404,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,362,000 | 863,000 | 2,869,000 | 1,897,000 | 1,008,000 |
| Capital Expenditure | -375,000 | -355,000 | -678,000 | -496,000 | -612,000 |
| Free Cash Flow | 987,000 | 508,000 | 2,191,000 | 1,401,000 | 396,000 |